An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells
Open Access
- 15 December 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (13), 4427-4435
- https://doi.org/10.1182/blood-2007-05-090621
Abstract
Leukemia stem cells (LSCs) are thought to play a central role in the pathogenesis of acute leukemia and likely contribute to both disease initiation and relapse. Therefore, identification of agents that target LSCs is an important consideration for the development of new therapies. To this end, we have previously demonstrated that the naturally occurring compound parthenolide (PTL) can induce death of human LSCs in vitro while sparing normal hematopoietic cells. However, PTL has relatively poor pharmacologic properties that limit its potential clinical use. Consequently, we generated a family of PTL analogs designed to improve solubility and bioavailability. These studies identified an analog, dimethylamino-parthenolide (DMAPT), which induces rapid death of primary human LSCs from both myeloid and lymphoid leukemias, and is also highly cytotoxic to bulk leukemic cell populations. Molecular studies indicate the prevalent activities of DMAPT include induction of oxidative stress responses, inhibition of NF-κB, and activation of p53. The compound has approximately 70% oral bioavailability, and pharmacologic studies using both mouse xenograft models and spontaneous acute canine leukemias demonstrate in vivo bioactivity as determined by functional assays and multiple biomarkers. Therefore, based on the collective preclinical data, we propose that the novel compound DMAPT has the potential to target human LSCs in vivo.Keywords
This publication has 25 references indexed in Scilit:
- Constitutive Histone H2AX Phosphorylation and ATM Activation, the Reporters of DNA Damage by Endogenous OxidantsCell Cycle, 2006
- High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor SurvivalClinical Cancer Research, 2005
- The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancerMolecular Cancer Therapeutics, 2005
- Nuclear factor-κB inhibitors as sensitizers to anticancer drugsNature Reviews Cancer, 2005
- Characterization of acute lymphoblastic leukemia progenitor cellsBlood, 2004
- Mechanisms controlling pathogenesis and survival of leukemic stem cellsOncogene, 2004
- The transcription factor NF-κB: control of oncogenesis and cancer therapy resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2000
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- A cell initiating human acute myeloid leukaemia after transplantation into SCID miceNature, 1994
- Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow.The Journal of Experimental Medicine, 1992